- Drugs
- Tuesday, 21 Jan 2020
Global Recall of the Common Heartburning Drugs Over the Risk of Cancer
Ranitidine is an OTC (over-the-counter) & prescription drug with H2 (histamine-2) blocker that is mainly used for decreasing the amount stomach acid. OTC ranitidine has been approved of preventing as well as relieving heartburn accompanying acid ingestion followed by sour stomach. Prescription ranitidine is approved for numerous symptoms, comprising treatment plus prevention of stomach & intestine ulcers.
However, recent recalls in terms of ranitidine, posted by the Food and Drug Administration (FDA) lately, are the latest in a series that initiated in September 2019, when the FDA alerted the public to the presence of a probable human carcinogen, N-Nitrosodimethylamine (NDMA), in a few ranitidine medications. Ranitidine is the generic form of Zantac that is obtainable over the counter & by prescription.
The FDA's declaration impelled national drugstore chains to pull ranitidine medications from their shelves “out an abundance of caution.” Several drug manufacturers followed with voluntary recalls for their medications. Now, more are joining the line including Appco Pharma LLC as well as Northwind Pharmaceuticals who are voluntarily recalling prescription ranitidine hydrochloride capsules & ranitidine tablets (150 mg and 300 mg, manufactured by Glenmark Pharmaceutical Inc.) respectively. Also, giants like Denton Pharma Inc.and Mylan Pharmaceuticals have also started recalling all of its unexpired ranitidine tablets plus nizatidine capsules respectively.
All of these companies referred to NDMA as impurities in the pills as key reason for recalls, however have even claimed for no adverse health effects reported until now due to these medicines. In addition, patients are still being advised to stop taking these medications immediately. Nevertheless, a number of other common drugs used for heartburn & ulcer drugs are still approved by the regulatory bodies that include Tagamet (cimetidine), Pepcid (famotidine), Nexium (esomeprazole, Prilosec (omeprazole) and Prevacid (lansoprazole).
Related Industry Updates
UnitedHealth rises on 'minimal' COVID-19 impact on results & maintained its forecast
Apr 15, 2020
Applied BioMath, LLC Announces Collaboration with Northern Biologics
Apr 22, 2020
Tiamulin Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2027
Mar 23, 2021
Clinical Trial Imaging Market is expected to reach US$ 2,480.32 million by 2028
May 23, 2023
Human Vaccine Adjuvants Market is expected to reach US$ 4,489.23 million by 2030
Jan 04, 2024
Eybna and CannaSoul, Top Cannabis R&D Firms, Join Forces to Prove a Proprietary Terpene Formulation for Treating Viral Infections via Modulation of Cytokine Storm
Apr 22, 2020
Pharmaceutical Waste Disposal and Management Market is expected to reach US$ 6,377.95 million by 2030
Jan 10, 2024